Imbruvica (Ibrutinib): First Drug Approved for the Treatment of Patients with Waldenström's Macroglobulinemia.
Lisa A
LA
Raedler
Blood. 2013 Aug 15;122(7):1222-32
23836557
J Hematol Oncol. 2013 Aug 19;6:59
23958373
N Engl J Med. 2012 Aug 30;367(9):826-33
22931316
J Natl Compr Canc Netw. 2012 Oct 1;10(10):1211-9
23054875
Blood Cancer J. 2015 Mar 27;5:e394
25815903
N Engl J Med. 2015 Apr 9;372(15):1430-40
25853747
Blood. 2014 Mar 13;123(11):1637-46
24366360